Diagnostics

Profusa Shareholders Approve Strategic Initiatives at 2026 Annual Meeting, Supporting PanOmics Acquisition, Balance Sheet Strengthening and Nasdaq Compliance Efforts

BERKELEY, Calif., June 24, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (Nasdaq: PFSA), a digital health company pioneering next-generation biosensing technologies, announces...

Digital Health Market Size to Reach USD 1,830.4 Billion by 2033, Driven by Rising Adoption of Telehealth, mHealth, AI-Based Solutions, and Connected Healthcare Technologies: Grand View Research, Inc.

AI in Healthcare Market to Reach USD 505.6 Billion by 2033, Driven by Rapid Adoption of AI-Powered Clinical Solutions and Digital Healthcare Transformation

Global AI in Healthcare Market Expected to Expand at 38.90% CAGR from 2026 to 2033 as Healthcare Systems Embrace Predictive...

xCures Closes $46 Million Series B Financing to Transform Fragmented Medical Records into Decision-ready Data through its Clinical Clarity Engine

New capital brings total funding to more than $76 million and will fuel continued expansion of the company's platform for...

Quest Diagnostics Receives New York State Approval for Haystack MRD®, Broadening Patient Access to ctDNA Minimal Residual Disease Testing

Achieving the rigorous laboratory standard broadens access for providers and patients in New York; applies to use of Haystack MRD...

Yunara Life Debuts Hybrid App and NYC Flagship, Launching the Future of Preventive Healthcare, Where Healthy Habits Earn Massages, Botox, Facials, and Wellness Rewards

Powered by a leadership team and advisory board with experience across One Medical, CityMD, Columbia University, Oracle, and e.l.f. Beauty,...

error: Content is protected !!